Tom Denney

Lunovus Enhances Its Eyecare Software and Service Solutions with Acquisition of Diamond Studios

Retrieved on: 
Friday, November 17, 2023

Lunovus LLC, a physician-owned pioneer in the eyecare industry, known for its advanced medical software and eye care supplementation solutions, has officially acquired Diamond Studios, a distinguished software development and media firm.

Key Points: 
  • Lunovus LLC, a physician-owned pioneer in the eyecare industry, known for its advanced medical software and eye care supplementation solutions, has officially acquired Diamond Studios, a distinguished software development and media firm.
  • As part of its commitment to excellence, Lunovus is channeling resources into Diamond Studios to expand its range of services and product offerings.
  • Over the past five years, Diamond Studios has played a critical role in developing the Lunovus Doc2Home platform.
  • Embracing the future, Lunovus LLC and Diamond Studios share a key commitment to innovation, poised to deliver top-tier solutions in the dynamic fields of software development and media.

Impact BioMedical Scientific Partner GRDG Sciences to be Featured in New Documentary

Retrieved on: 
Wednesday, October 19, 2022

ROCHESTER, N.Y., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Daryl Thompson, founder of GRDG Sciences LLC (“GRDG”) in Winter Haven, Florida, has spent a career working just out of the spotlight and inventing biological and medical technologies that, when fully deployed, could better the lives of people around the world.

Key Points: 
  • Early in the development process, GRDG began a working relationship with Impact Biomedical, who partnered with GRDG and provided investment capital to support its research.
  • Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS.
  • Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades.
  • By tapping into the scientific expertise of GRDG Sciences, LLC, Impact BioMedical pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological, oncological and immuno -related diseases.

"A Real-Life Mission Impossible" -- Global Research and Discovery Group Steps in The Spotlight for Documentary, "The BioQuest" -- Filming to Start December 3

Retrieved on: 
Thursday, October 20, 2022

For GRDG, that team included a Washington insider, an investor and a lab.

Key Points: 
  • For GRDG, that team included a Washington insider, an investor and a lab.
  • "The NIH model is great for research, but it takes a long time to get anything done," he said.
  • These new plastics are specifically focused on solutions for common products such as cups, plates, utensils, plastic bags, and countertops.
  • Diamond Studios, an Emmy Award-winning production company from Tampa, Fla., will produce the documentary, which will begin filming in December 2022.